As the global community observes World Tuberculosis (TB) Day, we confront the reality of a disease that, despite centuries of awareness and decades of medical advancements, continues to inflict suffering on millions worldwide. The fight against TB, a disease deeply entwined with socioeconomic factors, is as much a medical battle as it is a testament to our collective resolve to address global health inequities.
In 2022, TB claimed 1.3 million lives, positioning it as the second deadliest infectious disease after COVID-19. Its impact is particularly devastating among individuals living with HIV and in regions burdened by antimicrobial resistance. The disease’s toll on productivity and life expectancy underscores a grim reality: TB predominantly affects adults in their prime, casting a long shadow over communities and economies.
Our focus turns toward the regions hardest hit by this epidemic. The African region, for example, accounted for a quarter of the world’s new TB cases in 2022, reflecting a broader trend where over 80% of TB cases are concentrated in low- and middle-income countries. This geographic skew highlights the critical need for targeted health interventions and resource allocation to those most at risk.
The threat of multidrug-resistant TB (MDR-TB) exacerbates the urgency of our mission. In 2022, the world saw 410,000 new cases of rifampicin-resistant TB, a stark reminder of the disease’s evolving challenge. Addressing MDR-TB requires not only medical innovation but also a steadfast commitment to patient care, ensuring that those affected receive the comprehensive support they need to overcome this formidable foe.
Amid these challenges, we also witness remarkable resilience and progress. Between 2010 and 2022, global and regional efforts have saved millions of lives, testament to the power of concerted action and strategic health initiatives. Yet, to achieve the End TB Strategy’s goal of a 50% reduction in TB incidence by 2025, we must accelerate our efforts, leveraging every tool and insight at our disposal.
Central to our strategy at the Oxygen Alliance is enhancing the role of oxygen therapy, an essential yet often overlooked component of TB care. For patients grappling with severe TB or TB/HIV coinfection, oxygen isn’t just a treatment—it’s a critical lifeline that can significantly alleviate symptoms and improve quality of life. In this light, ensuring reliable access to oxygen therapy forms the bedrock of our mission, mirroring our overarching commitment to fortify health systems to be both resilient and responsive.
Our focus is on advocating for the crucial maintenance and repair of biomedical devices, ensuring that every piece of medical equipment, especially those crucial for oxygen therapy, is functional and patient-ready. By marshaling a multidisciplinary consortium of partners—spanning governments, biomedical engineers, NGOs, manufacturers, and academic institutions—we’re not just responding to immediate needs but are proactively building a healthcare infrastructure that prioritizes durable, quality care.
Through advocacy, we highlight the indispensability of healthcare technology management, championing the cause in LMICs where the need is greatest. Our data-driven initiatives, rooted in biomedical engineering indicators, provide the insights necessary to elevate healthcare technology management, thereby enhancing patient safety and treatment outcomes. Education and knowledge dissemination form another pillar of our approach, ensuring that stakeholders are equipped with the understanding and skills to uphold equipment integrity and functionality.
As we commemorate World TB Day, we are called to action, inspired by the progress we’ve witnessed and sobered by the challenges that remain. The theme “Yes! We can end TB!” is more than a slogan; it is a declaration of our collective commitment to a future where TB no longer casts its shadow over any community. By championing patient-centered care, embracing innovation, and strengthening health systems, we can turn the tide against TB, forging a path toward health, equity, and resilience for all.
References